Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pruritus, Vaccination site rash
Clinical narrative: lingering aching all over now at one week after shot; swollen red upper arm; Severe aching shoulders, head, Back; Severe aching shoulders, head, Back; Severe aching shoulders, head, Back; Slight fever; chills; Nausea; swollen red upper arm; itching and rash at injection site; itching and rash at injection site; Booster; This is a spontaneous report received from non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 70 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 03Dec2021 11:30 (Batch/Lot number: unknown) at the age of 70 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "Depression" (unspecified if ongoing), notes: other medical history: Depression, anxiety, severe osteo, arthritis, asthma/allergies, fibromyalgia; "anxiety" (unspecified if ongoing); "severe osteoarthritis" (unspecified if ongoing); "asthma/allergies" (unspecified if ongoing), notes: Asthma; "asthma/allergies" (unspecified if ongoing), notes: allergies; "fibromyalgia" (unspecified if ongoing); "known allergies: peanuts" (unspecified if ongoing), notes: known allergies: peanuts, wheat, grass, mold, cats,, dairy & others I can't figure out; "known allergies: wheat" (unspecified if ongoing); "known allergies: grass" (unspecified if ongoing); "known allergies: mold" (unspecified if ongoing); "known allergies: cats" (unspecified if ongoing). Concomitant medication(s) included: OMEPRAZOLE; DULOXETINE; BENADRYL; TYLENOL; AMBIEN. Vaccination history included: Bnt162b2 (Dose Number: 2, Batch/Lot No: Unknown. Not available/provided to reporter at the time of report completion, Location of injection: Arm Left, Vaccine Administration Time: 12:00 PM), administration date: May2021, when the patient was 70 years old, for COVID-19 Immunization; Bnt162b2 (Dose Number: 1, Batch/Lot No: Unknown. Not available/provided to reporter at the time of report completion, Location of injection: Arm Left, Vaccine Administration Time: 01:00 PM), administration date: Apr2021, when the patient was 70 years old, for COVID-19 Immunization. The following information was reported: IMMUNISATION (non-serious) with onset 03Dec2021 11:30, outcome "unknown", described as "Booster"; ARTHRALGIA (non-serious), HEADACHE (non-serious), BACK PAIN (non-serious) all with onset 03Dec2021 17:00, outcome "recovered with sequelae" (2021) and all described as "Severe aching shoulders, head, Back"; PYREXIA (non-serious) with onset 03Dec2021 17:00, outcome "recovered with sequelae" (2021), described as "Slight fever"; CHILLS (non-serious) with onset 03Dec2021 17:00, outcome "recovered with sequelae" (2021), described as "chills"; NAUSEA (non-serious) with onset 03Dec2021 17:00, outcome "recovered with sequelae" (2021), described as "Nausea"; PERIPHERAL SWELLING (non-serious), ERYTHEMA (non-serious) all with onset 03Dec2021 17:00, outcome "recovered with sequelae" (2021) and all described as "swollen red upper arm"; VACCINATION SITE PRURITUS (non-serious), VACCINATION SITE RASH (non-serious) all with onset 03Dec2021 17:00, outcome "recovered with sequelae" (2021) and all described as "itching and rash at injection site"; PAIN (non-serious), outcome "recovered with sequelae" (2021), described as "lingering aching all over now at one week after shot". Therapeutic measures were not taken as a result of arthralgia, headache, back pain, pyrexia, chills, nausea, peripheral swelling, vaccination site pruritus, vaccination site rash, pain, erythema.  Additional Information: Severe aching shoulders, head, Back, Slight fever and chills, nausea, swollen red upper arm, itching and rash at injection site. lingering aching all over now at one week after shot. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with covid prior vaccination and was not tested post vaccination.  The lot number for bnt162b2 was not provided and will be requested during follow up.